Yordanov Angel D, Tantchev Latchezar, Vasileva Polina, Strashilov Strahil, Vasileva-Slaveva Mariela, Konsoulova Assia
Department of Gynaecological Oncology, Medical University of Pleven, Pleven, Bulgaria.
Obstetrics and Gynaecology Clinic, Acibadem City Clinic Hospital "Tokuda", Sofia, Bulgaria.
Prz Menopauzalny. 2020 Mar;19(1):30-34. doi: 10.5114/pm.2020.95333. Epub 2020 Apr 27.
Uterine smooth muscle tumours of uncertain malignant potential (STUMPs) are a rare histologically heterogeneous group of uterine smooth muscle tumours (SMTs). Their malignant potential and clinical differentiation between leiomyoma and leiomyosarcoma remain uncertain prior to surgical removal.
To investigate the patients and tumour characteristics of patients with STUMPs and to propose algorithms for optimal diagnosis, treatment, and follow-up management.
This was a single-centre retrospective cohort study of all patients who underwent surgery for a preoperative diagnosis of uterine myoma at the University Hospital "Dr. Georgi Stranski", Pleven, Bulgaria during a period of 33 months (from January 2013 until October 2015). Data were obtained from the medical history records. We performed descriptive analysis to characterise the patient population (e.g. demographics, age, contraceptive use, and complaints that led to the diagnosis) and the tumour characteristics. Last data were obtained prior May 2019.
A total of 320 medical records were retrospectively evaluated. The preoperative diagnosis of myoma was confirmed in 279 of the cases (89.4%). In 27 (8.3%) cases the final histological result was completely different. In 14 (2.3%) a histological postoperative diagnosis of STUMP was identified. All 14 STUMP lesions were intramural with a median size of 7.5 cm (range 3.5 to 15 cm). The median age at diagnosis of STUMP was 45.4 years (range 36 to 52 years), and 92.9% ( = 13) of the patients were premenopausal. Ultrasound data of a rapidly growing myoma were a reason for diagnosis in only three patients (25%), whereas 92.9% of the patients ( = 13) presented with heavy menstrual bleeding with or without anaemia. After surgery, none of the patients with STUMP experienced a relapse of the disease within the median follow-up time of 48 months ( = 40-78).
STUMP tumours are rare tumours, predominantly diagnosed in premenopausal women. They define a group of patients with very good long-term prognosis. Therefore, longer follow-up is needed to allow for conclusions on recurrence rate and survival.
子宫平滑肌肿瘤,恶性潜能未定(STUMPs)是一组罕见的、组织学上异质性的子宫平滑肌肿瘤(SMTs)。在手术切除前,它们的恶性潜能以及平滑肌瘤与平滑肌肉瘤之间的临床鉴别仍不明确。
研究STUMPs患者及其肿瘤特征,并提出最佳诊断、治疗及随访管理的算法。
这是一项单中心回顾性队列研究,研究对象为保加利亚普列文市“格奥尔基·斯特兰斯基博士”大学医院在33个月期间(2013年1月至2015年10月)因术前诊断为子宫肌瘤而接受手术的所有患者。数据来自病史记录。我们进行了描述性分析,以描述患者群体特征(如人口统计学、年龄、避孕措施使用情况以及导致诊断的症状)和肿瘤特征。最新数据截至2019年5月。
共对320份病历进行了回顾性评估。279例(89.4%)病例术前诊断为肌瘤得到证实。27例(8.3%)病例最终组织学结果完全不同。14例(2.3%)术后组织学诊断为STUMP。所有14个STUMP病变均位于肌壁间,中位大小为7.5cm(范围3.5至15cm)。STUMP诊断时的中位年龄为45.4岁(范围36至52岁),92.9%(n = 13)的患者处于绝经前。仅3例患者(25%)因肌瘤快速生长的超声数据而被诊断,而92.9%(n = 13)的患者出现月经过多伴或不伴贫血。术后,在中位随访时间48个月(范围40 - 78个月)内,STUMP患者均未出现疾病复发。
STUMP肿瘤是罕见肿瘤,主要诊断于绝经前女性。它们定义了一组长期预后非常好的患者。因此,需要更长时间的随访才能得出复发率和生存率的结论。